GlassScriptPhysician profile
Chase Nathaniel Witter
NPI 1073182648
$3,818.92
in general payments reported to CMS, 2019-2025
20 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $734 · 2023: $320 · 2024: $2,090 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,157 · Travel and Lodging: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.09 |
| Travel and Lodging | $717.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,569.83 | 2022-2024 | Ortholoc 3di, Infinity Adaptis, Citrefix |
| Medical Device Business Services, INC. | $429.99 | 2021-2022 | |
| Treace Medical Concepts, INC. | $296.84 | 2022-2024 | |
| Nevro Corp. | $177.52 | 2023-2024 | Senza |
| Paragon 28, INC. | $174.50 | 2022-2024 | Portfolio, Ankle Fracture, Monkey Bars |
| Kerecis Limited | $168.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $140.73 | 2022 | |
| International Life Sciences | $138.03 | 2024 | Flexband |
| Organogenesis INC. | $115.60 | 2024-2025 | Puraply Wound Matrix, Puraply Am |
| Fusion Orthopedics USA, LLC | $101.54 | 2024 | |
| Zimmer Biomet Holdings, INC. | $94.19 | 2022-2024 | Avitus Bone Harvester, Stratum Foot Plating System |
| Crossroads Orthopedics, LLC | $85.15 | 2022-2024 | |
| Aroa Biosurgery Incorporated | $81.51 | 2024 | |
| W. L. Gore & Associates, INC. | $66.00 | 2025 | Gore Viabahn Endoprosthesis |
| Bone Support INC. | $63.24 | 2025 | Cerament G, Ceramentbone Void Filler |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43.12 | 2024 | Stravix |
| Phathom Pharmaceuticals, INC. | $24.56 | 2025 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.52 | 2025 | Caplyta |
| Globus Medical, INC. | $18.07 | 2025 | Senza |
| Reprise Biomedical, INC. | $10.02 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Witter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.